sepsi
one
common
caus
death
sever
injur
patient
worldwid
earli
detect
sepsi
still
solv
clinic
practic
delay
diagnosi
often
contribut
inappropri
antimicrobi
treatment
subsequ
high
mortal
sepsi
biomark
produc
host
respons
infect
tradit
biomark
polypeptid
andor
protein
deriv
respons
omicsbas
biomark
screen
kind
molecul
host
respons
highthroughout
omic
technolog
emerg
review
describ
tradit
potenti
omicsbas
sepsi
biomark
current
avail
literatur
combin
biomark
would
refin
identif
sepsi
clinic
experiment
sepsi
studi
sepsi
one
lead
fatal
caus
critic
injur
ill
patient
world
despit
recent
advanc
comprehens
manag
trauma
patient
sepsi
still
lifethreaten
condit
poor
outcom
risk
factor
patient
develop
sepsi
usual
refer
physiolog
characterist
underli
ill
clinic
treatment
background
patient
one
factor
suscept
sepsi
vulner
popul
sepsi
elderli
infant
patient
chronic
diseas
patient
sever
trauma
burn
immunocompromis
receiv
immunosuppress
therapi
malnourish
debilit
biomark
molecular
indic
help
doctor
diagnos
ill
predict
outcom
identifi
peopl
suscept
biomark
quantifi
measur
biolog
homeostasi
defin
normal
statu
provid
frame
refer
predict
abnorm
pathogen
process
make
impact
clinic
decis
make
time
commonli
propos
sepsi
infect
biomark
includ
creactiv
protein
crp
procalcitonin
pct
cytokin
osteopontin
chemokin
macrophag
migrat
inhibitori
factor
mif
highmobilitygroup
box
solubl
receptor
solubl
trigger
receptor
express
myeloid
cell
solubl
urokinasetyp
plasminogen
activ
receptor
supar
etc
given
complic
pathophysiolog
sepsi
involv
hundr
mediat
singl
molecul
unlik
identifi
one
singl
biomark
abl
satisfi
exist
need
expect
sepsi
research
manag
crp
exampl
frequent
use
assess
presenc
infect
sepsi
posit
correl
plasma
level
risk
organ
dysfunct
death
howev
plasma
concentr
crp
may
increas
minor
infect
adequ
reflect
sever
infect
remain
high
level
sever
day
even
overstay
infect
besid
crp
may
experi
increas
inflamm
caus
noninfecti
etiolog
tumor
tissu
necrosi
oper
explain
nonspecif
earli
stage
sepsi
biomark
meanwhil
pct
perceiv
potenti
biomark
list
one
diagnost
criteria
sepsi
recent
metaanalysi
pct
includ
studi
found
mean
sensit
specif
respect
area
receiv
oper
characterist
curv
auc
although
pct
thought
help
biomark
earli
diagnosi
sepsi
critic
ill
patient
suitabl
recommend
singl
definit
diagnost
test
therefor
research
put
forward
combin
biomark
may
overcom
limit
mention
prospect
cohort
studi
includ
patient
system
inflammatori
respons
syndrom
sir
kofo
et
al
found
auc
six
biomarkerssupar
mif
pct
neutrophil
count
crp
detect
bacteri
caus
inflamm
rang
method
report
xiong
et
al
discuss
statist
estim
optimum
linear
combin
test
associ
maximum
area
roc
curv
kofo
got
combin
auc
sixmark
test
consequ
sixmark
test
better
diagnost
accuraci
detect
bacteri
versu
nonbacteri
caus
inflamm
significantli
greater
singl
marker
similarli
anoth
prospect
research
among
critic
ill
patient
bioscor
combin
polymorphonuclear
neutrophil
pmn
index
togeth
pct
serum
level
put
forward
diagnos
sepsi
better
perform
auc
individu
biomark
extern
confirm
valid
cohort
patient
correctli
classifi
model
although
combin
biomark
improv
diagnost
sensit
specif
due
factor
timeconsum
econom
cost
amount
sampl
feasibl
biomark
detect
method
limit
applic
clinic
practic
still
need
prospect
studi
conduct
multicent
costeffect
circul
dna
includ
nuclear
dna
ndna
mitochondri
dna
mtdna
either
activ
releas
releas
passiv
blood
stream
ruptur
necrosi
host
cell
nucleic
acid
releas
plasma
sepsi
could
serv
danger
associ
molecular
pattern
damp
make
potenti
biomark
condit
clinic
studi
found
plasma
cytokin
concentr
well
ndna
mtdna
level
septic
shock
patient
increas
onset
septic
shock
remain
elev
first
day
septic
shock
ndna
level
consist
correl
plasma
cytokin
concentr
well
shockrel
paramet
norepinephrin
infus
rate
marker
organ
damag
total
bilirubin
creatinin
find
indic
relationship
plasma
ndna
level
inflammatori
respons
also
demonstr
ndna
level
associ
marker
shock
organ
damag
septic
shock
patient
genom
disciplin
genet
emerg
field
explain
physiolog
pathophysiolog
event
point
view
complet
set
dna
includ
recombin
dna
dna
sequenc
method
bioinformat
sequenc
assembl
analyz
function
structur
genom
sepsi
regard
polygen
syndrom
initi
infect
genet
play
crucial
role
suscept
respons
infect
genet
predisposit
influenc
clinic
outcom
infecti
diseas
gene
polymorph
defin
regular
occurr
two
allel
particular
chromosom
locat
sever
polymorph
gene
broadli
involv
inflamm
immun
coagul
link
suscept
sepsi
outcom
sepsi
becom
focu
gene
associ
studi
sepsi
well
snp
common
type
polymorph
substitut
delet
insert
singl
nucleotid
occur
approxim
per
base
pair
human
dna
snp
lead
alter
protein
chang
amount
normal
protein
express
discern
chang
protein
function
studi
snp
genotyp
sepsi
help
identifi
potenti
marker
suscept
sever
clinic
outcom
extens
research
snp
genotyp
main
gene
toll
like
receptor
tlr
lipopolysaccharidebind
protein
lbp
cytokin
coagul
factor
provid
valuabl
inform
sepsi
exampl
burn
patient
polymorph
time
like
develop
sever
sepsi
none
significantli
associ
mortal
snp
associ
increas
mortal
patient
gramposit
sepsi
traumat
injuri
may
repres
novel
marker
risk
death
critic
injur
patient
recent
found
new
associ
vascular
endotheli
growth
factor
vegf
cc
genotyp
risk
develop
acut
kidney
injuri
aki
sever
sepsi
patient
genomewid
snp
genotyp
assay
allow
detect
hundr
thousand
snp
accur
singl
experi
expect
great
applic
prospect
find
novel
sepsi
susceptibilityassoci
snp
genotyp
order
evalu
valid
studi
translat
concept
bedsid
sever
import
factor
kept
mind
potenti
confound
variabl
recogn
match
posit
associ
studi
replic
studi
valid
analyz
basi
primari
hypothesi
multipl
comparison
larg
scale
collabor
studi
sepsi
susceptibilityassoci
snp
genotyp
need
perform
sake
possibl
new
risk
factor
genet
background
sepsi
develop
gene
concern
immun
inflamm
subject
epigenet
regul
refer
herit
chang
gene
express
relat
direct
dna
sequenc
chang
dna
methyl
histon
posttransl
modif
play
vital
role
epigenet
control
gene
express
strongli
impact
host
defens
respons
sepsi
induc
epigenet
chang
dendrit
cell
lymphocyt
render
host
immun
defici
long
period
initi
sepsi
challeng
latephas
immunosuppress
sepsi
strengthen
postmortem
studi
suppress
proinflammatori
gene
product
subsequ
immun
cell
activ
prolifer
epigenet
mechan
put
forward
influenc
stage
sepsi
may
provid
better
understand
septic
mechan
also
yield
import
biomark
dna
methyl
addit
methyl
group
cytosin
adenin
nucleotid
replac
biolog
marker
high
specif
sensit
prognost
efficaci
retrospect
investig
show
calcitoninrel
polypeptid
calca
gene
promot
methyl
vari
differ
type
preterm
bacteri
sepsi
base
find
anoth
studi
demonstr
global
dna
methyl
vari
significantli
among
newborn
sepsi
without
sepsi
specif
recent
studi
analyz
cpg
methyl
statu
epigenom
septic
nonsept
babi
icu
patient
given
biolog
clinic
signific
found
differenti
methyl
cpg
locat
gene
panel
differenti
methyl
protocadherin
pcdhb
gene
play
vital
role
leukocyt
cell
adhes
wnt
signal
pathway
gene
play
vital
role
calcium
depend
cell
cell
adhes
immunolog
process
like
antigen
process
present
sepsi
suppress
leukocyt
cell
adhes
migrat
may
exagger
diseas
sever
poor
outcom
due
multipl
organ
dysfunct
therefor
studi
provid
novel
insight
role
dna
methyl
neonat
sepsi
howev
studi
call
explor
clinic
relev
well
relat
therapeut
approach
observ
find
mention
sepsi
biomark
deriv
develop
genom
technolog
summar
tabl
immun
respons
involv
sepsi
complic
exact
molecular
mechan
remain
fulli
elucid
balanc
proinflammatori
respons
antiinflammatori
respons
close
relat
express
regul
relev
gene
henc
evalu
key
gene
express
profil
high
throughput
dna
chip
may
reveal
immun
statu
septic
patient
research
found
specif
chang
gene
express
microarray
certain
organ
tissu
septic
mice
model
includ
heart
liver
spleen
leucocyt
accordingli
lukaszewsk
recruit
icu
patient
risk
develop
sepsi
mrna
express
level
tnfa
fasl
blood
leukocyt
measur
daili
basi
mean
realtim
revers
transcript
pcr
rtpcr
analyz
nonlinear
techniqu
neural
network
analysi
data
correctli
predict
onset
sepsi
averag
patient
case
day
clinic
diagnosi
high
sensit
select
respect
sutherland
et
al
evalu
transcript
profil
circul
white
blood
cell
icu
sepsi
patient
postsurg
patient
healthi
control
microarray
multiplex
tandem
mt
pcr
panel
express
marker
identifi
predict
sepsi
within
mix
inflammatori
popul
auc
sepsi
uniqu
gene
express
profil
differ
uninfect
inflamm
becom
appar
prior
clinic
manifest
sepsi
h
case
specif
gene
express
profil
may
involv
function
innat
immun
cytokin
receptor
cell
differenti
well
protein
synthesi
may
make
refer
earli
diagnosi
sepsi
howev
import
limit
transcriptom
partial
reflect
steadyst
mrna
abund
degre
mrna
abund
influenc
multipl
factor
provid
direct
inform
gene
end
product
protein
posttransl
modifi
protein
function
come
sampl
use
rna
sourc
contradict
whole
blood
approach
may
difficult
interpret
confound
data
rna
reason
heterogen
among
blood
cell
popul
cellspecif
approach
possibl
miss
relev
express
inform
cell
due
complex
clinic
sepsi
highlight
necess
link
theori
clinic
practic
microrna
mirna
class
short
rna
nucleotid
length
regul
gene
express
posttranscript
manner
via
sequencespecif
interact
target
site
mrna
associ
variou
physiolog
patholog
process
level
mirna
serum
plasma
consist
among
individu
speci
resist
rnase
digest
stabl
even
freezeandthaw
long
term
storag
stabil
mirna
make
potenti
use
candid
diagnost
clinic
applic
although
sourc
circul
mirna
still
unclear
prove
link
among
rang
diseas
circul
mirna
cancer
trauma
acut
pancreat
hepat
come
sepsi
use
genomewid
mirna
profil
microarray
peripher
blood
leukocyt
quantit
rtpcr
vasilescu
found
level
significantli
reduc
leukocyt
plasma
sepsi
patient
neg
correl
level
diseas
sever
measur
sequenti
organ
failur
assess
sofa
score
made
biomark
earli
sepsi
similarli
zeng
investig
level
peripher
blood
leukocyt
sepsi
patient
rtpcr
found
express
level
significantli
decreas
sepsi
patient
could
reflect
sever
sepsi
certain
degre
made
marker
reflect
situat
inflammatori
respons
also
made
prognost
marker
sepsi
recent
higher
serum
level
found
among
sepsi
patient
icu
significantli
correl
diseas
sever
classic
marker
inflamm
bacteri
infect
well
organ
failur
high
level
consid
independ
biomark
unfavor
prognosi
critic
ill
patient
howev
given
pathophysiolog
process
sepsi
involv
varieti
tissu
organ
simpl
screen
mirna
differenti
express
leukocyt
may
omit
secret
cell
wang
et
al
use
genomewid
microarray
identifi
differenti
serum
mirna
surviv
nonsurviv
sepsi
patient
valid
differenti
express
rtpcr
larger
group
serum
togeth
sepsi
stage
sepsisrel
organ
failur
assess
score
better
predict
capabl
death
sepsi
patient
addit
serum
found
significantli
reduc
septic
patient
compar
sir
patient
healthi
control
might
serv
new
biomark
sepsi
high
specif
sensit
due
knowledg
serum
mirna
still
primari
stage
express
level
circul
mirna
differ
stage
sepsi
potenti
correl
injur
organ
need
investig
sum
point
view
gene
transcript
mirna
may
undertak
task
diagnos
sepsi
earli
stage
evalu
prognosi
well
becom
new
target
sepsi
therapi
discuss
epigenet
factor
includ
histon
modif
dna
methyl
also
contain
noncod
rna
ncrna
divers
size
gener
intergen
region
intron
enhanc
lncrna
transcript
longer
nucleotid
lack
proteincod
capac
peng
et
al
first
discov
widespread
differenti
express
lncrna
respons
sever
acut
respiratori
syndrom
coronaviru
sarscov
viru
infect
accordingli
possibl
link
lncrna
host
defens
respons
infect
lncrna
potenti
becom
new
class
biomark
new
therapeut
target
infecti
diseas
howev
function
lncrna
remain
larg
unexplor
need
futur
studi
regulatori
role
infect
transcriptomicsbas
biomark
mention
outlin
tabl
proteom
complet
set
protein
express
genet
materi
organ
proteom
analysi
express
local
function
interact
proteom
compar
immunolog
test
proteom
novel
method
advantag
high
throughput
high
sensit
specif
develop
proteom
allow
better
understand
molecular
base
concern
identif
cell
signal
modifi
protein
posttransl
modif
pathway
well
character
specif
biolog
marker
proteom
irreplac
clinic
signific
expans
applic
prospect
studi
sepsi
biomark
rabbit
sepsi
model
intraven
inject
pseudomona
aeruginosa
h
scald
discrep
express
protein
lymphocyt
found
matrixassist
laser
desorptionion
time
flight
mass
spectrometri
malditof
ms
relat
fold
assembl
transport
degrad
protein
signal
transmiss
inflamm
immun
energi
metabol
prolifer
differenti
apoptosi
cell
recent
research
differenti
express
protein
neutrophil
acinetobact
baumannii
sepsi
rat
identifi
use
twodimension
electrophoresi
mass
spectrometri
includ
antioxid
protein
signal
protein
cytoskeleton
regulatori
protein
energi
metabol
proteas
protein
may
play
key
role
kind
sepsi
provid
potenti
clue
earli
diagnosi
treatment
sepsi
clinic
identifi
proteom
analysi
significantli
higher
express
level
serum
sampl
sepsi
patient
consid
possibl
biomark
sepsi
paugamburtz
et
al
use
plasma
profil
coupl
proteinchip
array
surfaceenhanc
laser
desorpt
ioniz
timeoffli
mass
spectrometri
selditof
ms
analyz
plasma
postop
patient
found
combin
five
plasma
protein
peak
may
potenti
diagnost
biomark
postop
sepsi
patient
undergo
liver
transplant
even
protein
remain
identifi
valid
clinic
trial
although
mani
potenti
sepsi
biomark
reveal
genom
transcriptom
proteom
chang
cellular
metabol
sepsi
paid
attent
metabolom
emerg
omic
technolog
follow
genom
proteom
focus
metabol
product
molecular
weight
less
kd
physiolog
patholog
statu
analyz
biochem
event
cell
tissu
organ
evalu
diseas
sever
research
method
metabolom
mainli
includ
nuclear
magnet
reson
nmr
ga
chromatographymass
spectra
gcm
high
perform
liquid
chromatographymass
spectra
hplcm
develop
sepsi
involv
reaction
multipl
system
variou
level
signific
influenc
express
level
activ
metabol
enzym
detect
concentr
ratio
chang
metabolit
involv
better
understand
condit
prognosi
sepsi
may
achiev
earli
stage
metabol
profil
serum
septic
rat
cecal
ligat
punctur
achiev
help
nmr
lcm
septic
rat
especi
nonsurvivor
mani
free
fatti
acid
show
lower
level
may
consum
greatli
energi
suppli
sepsi
may
relat
prognosi
sepsi
moreov
rise
polyunsatur
fatti
acid
group
may
relationship
increas
antiinflammatori
effect
base
metabol
profil
analysi
model
outcom
predic
built
high
sensit
specif
provid
novel
method
sepsi
prognosi
judgment
nmrbase
metabol
profil
reveal
differ
metabolit
energi
metabol
inflamm
lung
tissu
bronchoalveolar
lavag
bal
fluid
serum
sampl
septic
rat
control
rat
septic
rat
creatin
concentr
increas
three
type
sampl
wherea
alanin
phosphoethanolamin
concentr
increas
lung
tissu
serum
myoinositol
increas
lung
tissu
decreas
bal
fluid
addit
acetoacet
increas
wherea
format
decreas
serum
construct
predict
model
diagnosi
sepsi
use
partial
leastsquar
discrimin
analysi
preliminari
goal
sepsi
diagnosi
achiev
possibl
sepsi
biomark
screen
applic
proteom
metabolom
technolog
summar
tabl
sepsi
involv
sophist
pathophysiolog
chang
among
variou
organ
differ
system
comprehens
identifi
sepsi
biomark
understand
sepsi
molecular
mechan
perspect
omic
may
provid
valuabl
inform
macroscop
authent
state
follow
infect
import
issu
involv
research
sepsi
biomark
criteria
septic
case
golden
standard
infect
current
still
depend
result
clinic
microbiolog
laboratori
howev
due
sever
diseas
load
type
growth
capac
pathogen
use
antibiot
treatment
may
show
neg
result
patient
clinic
manifest
infect
fals
posit
result
may
present
reason
contamin
therefor
whether
gold
standard
appropri
sepsi
need
reflect
investig
lack
effect
unit
assess
method
sepsi
biomark
especi
multicent
multiindex
research
valid
evalu
need
perform
pick
ideal
diagnost
indic
high
sensit
specif
field
data
statist
great
practic
use
clinic
practic
major
studi
sepsi
focu
singl
set
omic
technolog
tabl
rather
appli
combin
multipl
omic
approach
sinc
differ
omic
may
display
sepsi
mechan
variou
level
specif
molecul
particular
group
sepsisassoci
molecul
comprehens
applic
two
omic
may
provid
integr
inform
potenti
sepsi
biomark
mapit
algorithm
multi
analyt
pathway
infer
tool
exampl
enabl
principl
integr
epigenom
transcriptom
proteom
data
cancer
diagnosi
prognosi
biomark
discoveri
last
least
mention
lack
clear
insight
pathophysiolog
sepsi
process
extent
put
sepsi
biomark
research
applic
stateofart
technolog
explor
novel
view
progress
sepsi
biomark
promot
awar
understand
sepsi
